Revenue
2020
2021
2022
2023
2024
2025
Neurones (NRO)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | €857.2M | €810.4M | €741.2M | €665.4M | €579.9M | €524.5M |
| Operating expenses | €466.1M | €428.2M | €381.7M | €337.3M | — | — |
| Operating income | €75.6M | €77.9M | €75.9M | €72.9M | €61.6M | €51.9M |
| Operating margin | 8.82% | 9.62% | 10.23% | 10.96% | 10.62% | 9.89% |
| EBITDA | €106.4M | €107.6M | €99.0M | €81.4M | €69.1M | €60.4M |
| EBITDA margin | 12.41% | 13.28% | 13.35% | 12.24% | 11.92% | 11.52% |
| Net income | €61.9M | €63.2M | €58.6M | €51.8M | €42.9M | €35.0M |
| Net profit margin | 7.22% | 7.80% | 7.90% | 7.78% | 7.40% | 6.67% |
| Basic EPSper basic share | €2.14 | €2.17 | €2.04 | €1.83 | €1.56 | €1.27 |
| Diluted EPSper diluted share | €2.14 | €2.16 | €2.03 | €1.82 | €1.56 | €1.27 |